MCRB earnings

Seres Therapeutics (MCRB) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

MCRB earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 4, 2026-1.63––$593.00K
Q2 2026Aug 5, 20260.47––$736.00K
Q1 2026May 5, 2026-2.08-1.88-10.64%$358.00K
Q4 2025Mar 12, 2026-1.78––$438.00K
Q3 2025Nov 5, 20250.94––$351.00K
Q2 2025Aug 6, 2025-2.27-2.7216.54%$0.00
Q1 2025May 7, 2025-3.75-0.67-459.70%$0.00
Q3 2024Nov 13, 2024-6.60-1.55-325.64%$0.00
Q2 2024Aug 13, 2024-4.40-5.4819.73%$0.00
Q1 2024May 8, 2024-5.40-6.8320.98%$0.00
Q4 2023Mar 5, 2024-6.40––-$126.26M
Q3 2023Nov 2, 2023-7.40––$310.00K
Q2 2023Aug 8, 20237.2010.69-32.65%$126.47M
Q1 2023May 9, 2023-11.40––-$522.00K
Q4 2022Mar 7, 2023-0.54––$975.00K
Q3 2022Nov 2, 2022-9.80––$3.44M